Browse by Basel Contributors ID

Jump to: 2011 | 2010 | 2009 | 2008

2011

Ruhstaller, Thomas and Pless, Miklos and Dietrich, Daniel and Kranzbuehler, Helmut and von Moos, Roger and Moosmann, Peter and Montemurro, Michael and Schneider, Paul M. and Rauch, Daniel and Gautschi, Oliver and Mingrone, Walter and Widmer, Lucas and Inauen, Roman and Brauchli, Peter and Hess, Viviane. (2011) Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma : a Prospective, Multicenter Phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, Vol. 29, H. 6. pp. 626-631.

Hess, V. and Pratsch, S. and Potthast, S. and Lee, L. and Winterhalder, R. and Widmer, L. and Cescato, C. and Lohri, A. and Jost, L. and Stillhart, P. and Pestalozzi, B. and Herrmann, R.. (2010) Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC) : a phase I/II trial. Annals of oncology, Vol. 21, H. 12. pp. 2390-2395.

Bernhard, J. and Dietrich, D. and Glimelius, B. and Hess, V. and Bodoky, G. and Scheithauer, W. and Herrmann, R.. (2010) Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. British journal of cancer, Vol. 103, no. 9. pp. 1318-1324.

Koeberle, Dieter and Montemurro, Michael and Samaras, Panagiotis and Majno, Pietro and Simcock, Mathew and Limacher, Andreas and Lerch, Stefanie and Kovàcs, Katalin and Inauen, Roman and Hess, Vivianne and Saletti, Piercarlo and Borner, Markus and Roth, Arnaud and Bodoky, György. (2010) Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma : a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). The oncologist, Vol. 15. pp. 285-292.

Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1522-1528.

Ribi, K. and Koeberle, D. and Schuller, J. C. and Honegger, H. and Roth, A. and Hess, V. and Moosmann, P. and von Moos, R. and Borner, M. and Lombriser, N. and Pestalozzi, B. and Ruhstaller, T.. (2009) Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Vol. 17. pp. 1109-1116.

Hess, V. and Glimelius, B. and Grawe, P. and Dietrich, D. and Bodoky, G. and Ruhstaller, T. and Bajetta, E. and Saletti, P. and Figer, A. and Scheithauer, W. and Herrmann, R.. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. The Lancet oncology, Vol. 9. pp. 132-138.

Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. pp. 1288-1292.

Koeberle, D. and Burkhard, R. and von Moos, R. and Winterhalder, R. and Hess, V. and Heitzmann, F. and Ruhstaller, T. and Terraciano, L. and Neuweiler, J. and Bieri, G. and Rust, C. and Toepfer, M.. (2008) Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer, Vol. 98, no. 7. pp. 1204-1209.